中华皮肤科杂志 ›› 2022, Vol. 55 ›› Issue (6): 519-522.doi: 10.35541/cjd.20201263

• 研究报道 • 上一篇    下一篇

表型温和的1型神经纤维瘤病:5个家系基因突变分析

祝英1    郭韫懿1    张丹露1    郭碧蓉2    孙忠辉1   

  1. 1上海市奉贤区皮肤病防治所皮肤科,上海  201408;2安徽医科大学第三附属医院合肥市第一人民医院皮肤科,合肥  230022
  • 收稿日期:2020-12-31 修回日期:2021-10-31 发布日期:2022-06-02
  • 通讯作者: 孙忠辉;郭碧蓉 E-mail:szhgyy3344@163.com; guobr1983@163.com
  • 作者简介:作者要求在2022年6月前刊出
  • 基金资助:
    上海市奉贤区科委社会类科技发展基金项目(奉科20171003);皮肤病学教育部重点实验室(安徽医科大学)开放课题基金(AY2017-1-017)

Mutation analysis in 5 families with mild phenotypes of neurofibromatosis type 1

Zhu Ying1, Guo Yunyi1, Zhang Danlu1, Guo Birong2, Sun Zhonghui1   

  1. 1Department of Dermatology, Fengxian Institute of Dermatosis Prevention and Treatment, Shanghai 201408, China; 2Department of Dermatology, The Third Affiliated Hospital of Anhui Medical University, Hefei First People′s Hospital, Hefei 230022, China
  • Received:2020-12-31 Revised:2021-10-31 Published:2022-06-02
  • Contact: Sun Zhonghui; Guo Birong E-mail:szhgyy3344@163.com; guobr1983@163.com
  • Supported by:
    Social Science and Technology Development Fund of Shanghai Fengxian District Science and Technology Commission (Fengke 20171003); Open Research Fund of Ministry of Education Key Laboratory of Dermatology (Anhui Medical University) (AY2017-1-017)

摘要: 【摘要】 目的 检测表型温和的1型神经纤维瘤病(NF1)患者的基因突变。方法 2017年6月至2020年6月于上海市奉贤区皮肤病防治所皮肤科门诊收集5例表型温和、仅有皮损的NF1先证者及其家系成员,在家系调查的基础上,观察和记录NF1的临床表型,并利用二代靶向基因测序结合Sanger测序来检测和验证致病突变。结果 5例先证者都仅有皮损(包括咖啡斑、雀斑、神经纤维瘤),无其他系统损害;5个家系先证者共发现5种突变,分别位于NF1基因的不同外显子中,包括1个大片段缺失突变(hg38:chr17:31327199-31335928 del 8 730 bp)、1个剪切突变(c.7970+1G>T)、1个插入突变(c.3011 _3012insTATG,p.N1004fs*)、1个缺失突变(c.1754_1757delTAAC, p.T586Vfs*18)和1个无义突变(c.C503G,p.S168X),前3种是未经报道的新突变。结论 在5个先证者表型温和的NF1家系中检测出5种突变,鉴定出3种新突变,丰富了NF1的突变谱。

关键词: 神经纤维瘤病1型, DNA突变分析, 表型

Abstract: 【Abstract】 Objective To detect gene mutations in patients with mild phenotypes of neurofibromatosis type 1 (NF1). Methods From June 2017 to June 2020, 5 probands with mild phenotypes of NF1 only involving lesions and their family members were collected from Department of Dermatology, Fengxian Institute of Dermatosis Prevention and Treatment in Shanghai. Pedigree investigation was performed to evaluate the clinical phenotypes of NF1. The second-generation targeted gene sequencing combined with Sanger sequencing was performed to detect and verify pathogenic mutations. Results All the 5 probands only presented with skin lesions, including café-au-lait spots, freckles, neurofibromas, without other systemic involvement. A total of 5 mutations were identified in different exons of the NF1 gene in the 5 families, including 1 large-fragment deletion mutation (hg38: chr17:31327199-31335928 del 8 730 bp), 1 splicing mutation (C.7970+1G>T), 1 insertion mutation (C.3011_3012insTATG, p.N1004fs*), 1 deletion mutation (C.1754_1757delTAAC, p.T586Vfs*18), and 1 nonsense mutation (c.C503G, p.S168X), and the first 3 above mentioned mutations were unreported novel mutations. Conclusion Five mutations were identified in the 5 families with mild phenotypes of NF1, including 3 novel mutations, which expand the mutational spectrum of NF1.

Key words: Neurofibromatosis 1, DNA mutational analysis, Phenotype